Biographie et livres de Massimo Cristofanilli

Découvrez tout l'univers de l'auteur en livre numérique

Massimo Cristofanilli, MD, is an accomplished board-certified medical oncologist with more than two decades of experience as physician, investigator, researcher and leader. He has demonstrated original and innovative vision in the field of molecular diagnostics, liquid biopsy, translational research and drug development. Additionally, Dr. Cristofanilli has an extensive background in clinical trial design and is a key thought leader in the field of metastatic and locally advanced breast cancer. At Weill Cornell Medicine and NewYork-Presbyterian, Dr. Cristofanilli serves as the Director of Breast Medical Oncology, the Associate Director of Precision Oncology at the Meyer Cancer Center (MCC), and the co-leader of the MCC Breast Cancer Disease Management Team, as well as the Scientific Director of the Englander Institute of Precision Medicine (EIPM). Dr. Cristofanilli received his medical degree from the University “La Sapienza? in Rome with Honors where he subsequently completed his fellowship in medical oncology. He completed an Internal Medicine residency at Cabrini Medical Center in New York and a medical oncology fellowship at The University of Texas MD Anderson Cancer Center, where he also served as Faculty in the Department of Breast Medical Oncology for more than a decade.Dr. Cristofanilli has held several leadership positions over the years, including Chairman of Medical Oncology and Associate Director of Clinical Research at the Fox Chase Cancer Center and Associate Director of Translational Research at Thomas Jefferson University. From 2015-2021, Dr. Cristofanilli was Professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago where he also served as the Director of the Breast Disease Team, Director of the Robert Lurie Cancer Center OncoSET Precision Medicine Program, and Associate Director of Clinical Research. In addition to his clinical expertise, Dr. Cristofanilli’s research focuses on biomarkers of endocrine resistance in breast cancer, liquid biopsies and novel drug development. His research in the areas of novel drug development, circulating tumor cells (CTCs) and ctDNA have led to improved treatments for breast cancer. Dr. Cristofanilli is an internationally recognized expert in the research and treatment of Inflammatory Breast Cancer (IBC), the most aggressive and deadly form of breast cancer. He is the founder and President of the IBC International Consortium (IBC-IC). Additionally, Dr. Cristofanilli is globally recognized for his contributions on the detection of micrometastatic disease in breast cancer and a key opinion leader in drug development in hormone-receptor positive metastatic breast cancer. He has co-authored more than 400 peer-reviewed manuscripts.

Découvrez tous ses livres

Dernière parution

Ajouter à ma liste d'envies

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B

Carolina Reduzzi , Massimo Cristofanilli , Lorenzo Gerratana

Academic Press

2025-04-28

epub sans DRM

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part B, Volume 392 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on a...

180,41 €

Lire plus

Tous les ebooks de Massimo Cristofanilli en PDF et EPUB

3 résultat(s)


Ajouter à ma liste d'envies Overview of Inflammatory Breast Cancer: Updates Hamouda Boussen , Massimo Cristofanilli , Marwa Manai International Review of Cell and Molecular Biology, Volume 381 highlights new advances in the field, with this new volume presenting interesting topic on Overview of Inflammatory Breast Cancer: Updates. - Provides the authority and expertise of leading contributors... Parution : 2024-04-18 Format(s) : PDF, epub sans DRM Éditeur : Academic Press PDF epub sans DRM J'achète 180,41 €
Ajouter à ma liste d'envies Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A Massimo Cristofanilli , Lorenzo Gerratana , Carolina Reduzzi "Circulating Tumor Cells, from biotech innovation to clinical utility" provides an overview of the most recent technological and clinical advances with regards to the study of circulating tumor cells (CTCs) in solid tumors. The volumes cover studies on CTCs in breast,... Parution : 2023-09-21 Format(s) : PDF, epub sans DRM Éditeur : Academic Press PDF epub sans DRM J'achète 180,41 €
Ajouter à ma liste d'envies Liquid Biopsies in Solid Tumors Massimo Cristofanilli This volume, with chapters written by experts in the field of cancerous tumors, details the key factors associated with liquid biopsies in solid tumors: blood-based diagnostics; circulating tumor cells; enumeration and molecular analysis (association with breast... Parution : 2017-03-25 Format(s) : PDF, ePub Éditeur : Humana PDF ePub J'achète 147,69 €

Les livres numériques peuvent être téléchargés depuis l'ebookstore Numilog ou directement depuis une tablette ou smartphone.

PDF : format reprenant la maquette originale du livre ; lecture recommandée sur ordinateur et tablette
EPUB : format de texte repositionnable ; lecture sur tous supports (ordinateur, tablette, smartphone, liseuse)

Votre support de lecture	Format	Protection	Application
Ordinateur	-EPUB -PDF	DRM Adobe LCP	Lecture en ligne (streaming) Adobe Digital Editions(DRM Adobe) Thorium Reader (LCP)
Tablette et smartphone iOS / Android	EPUB PDF	LCP DRM Adobe	Application Louise Reader : IOS / Android(ne lit pas les fichiers protégés par Adobe DRM) Adobe Digital Edition : IOS/Android(Lit uniquement la DRM Adobe)
Liseuse	EPUB	DRM Adobe	Module de lecture de la liseuse
Liseuse Diva	EPUB	LCP DRM Adobe	Module de lecture de la liseuse Diva

Consultez l’aide pour en savoir plus.

Restez informé(e) des événements et promotions ebook

Paiements sécurisés

Carolina Reduzzi , Massimo Cristofanilli , Lorenzo Gerratana

Tous les ebooks de Massimo Cristofanilli en PDF et EPUB

Overview of Inflammatory Breast Cancer: Updates

Hamouda Boussen , Massimo Cristofanilli , Marwa Manai

Circulating Tumor Cells, From Biotech Innovation to Clinical Utility Part A

Massimo Cristofanilli , Lorenzo Gerratana , Carolina Reduzzi

Liquid Biopsies in Solid Tumors

Massimo Cristofanilli